lansoprazole has been researched along with Arrhythmias, Cardiac in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare lansoprazole with another proton pump inhibitor (PPI) during ceftriaxone treatment in terms of risk for ventricular arrhythmia, cardiac arrest, and in-hospital mortality." | 8.31 | Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole. ( Almufleh, A; Bai, AD; Rai, M; Razak, F; Srivastava, S; Verma, AA; Wilkinson, A, 2023) |
| "To compare lansoprazole with another proton pump inhibitor (PPI) during ceftriaxone treatment in terms of risk for ventricular arrhythmia, cardiac arrest, and in-hospital mortality." | 4.31 | Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole. ( Almufleh, A; Bai, AD; Rai, M; Razak, F; Srivastava, S; Verma, AA; Wilkinson, A, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, AD | 1 |
| Wilkinson, A | 1 |
| Almufleh, A | 1 |
| Rai, M | 1 |
| Razak, F | 1 |
| Verma, AA | 1 |
| Srivastava, S | 1 |
| Wolfes, J | 1 |
| Ellermann, C | 1 |
| Burde, S | 1 |
| Leitz, P | 1 |
| Bögeholz, N | 1 |
| Willy, K | 1 |
| Fehr, M | 1 |
| Eckardt, L | 1 |
| Frommeyer, G | 1 |
2 other studies available for lansoprazole and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole.
Topics: Adult; Aged; Arrhythmias, Cardiac; Ceftriaxone; Cohort Studies; Female; Heart Arrest; Humans; Inpati | 2023 |
Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts.
Topics: Action Potentials; Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; | 2020 |